» Articles » PMID: 23672709

Three-dimensional Scaffolds for Tissue Engineering Applications: Role of Porosity and Pore Size

Overview
Date 2013 May 16
PMID 23672709
Citations 630
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue engineering applications commonly encompass the use of three-dimensional (3D) scaffolds to provide a suitable microenvironment for the incorporation of cells or growth factors to regenerate damaged tissues or organs. These scaffolds serve to mimic the actual in vivo microenvironment where cells interact and behave according to the mechanical cues obtained from the surrounding 3D environment. Hence, the material properties of the scaffolds are vital in determining cellular response and fate. These 3D scaffolds are generally highly porous with interconnected pore networks to facilitate nutrient and oxygen diffusion and waste removal. This review focuses on the various fabrication techniques (e.g., conventional and rapid prototyping methods) that have been employed to fabricate 3D scaffolds of different pore sizes and porosity. The different pore size and porosity measurement methods will also be discussed. Scaffolds with graded porosity have also been studied for their ability to better represent the actual in vivo situation where cells are exposed to layers of different tissues with varying properties. In addition, the ability of pore size and porosity of scaffolds to direct cellular responses and alter the mechanical properties of scaffolds will be reviewed, followed by a look at nature's own scaffold, the extracellular matrix. Overall, the limitations of current scaffold fabrication approaches for tissue engineering applications and some novel and promising alternatives will be highlighted.

Citing Articles

Inducing Osteogenesis in Human Pulp Stem Cells Cultured on Nano-Hydroxyapatite and Naringin-Coated 3D-Printed Poly Lactic Acid Scaffolds.

Dawood R, Mahdee A Polymers (Basel). 2025; 17(5).

PMID: 40076089 PMC: 11902540. DOI: 10.3390/polym17050596.


Development and evaluation of BDNF-loaded PCL/PVA two-layer nerve guidance conduit with enhanced biomechanical and biological properties for peripheral nerve regeneration.

Fakhr M, Farsani M, Fath-Bayati L, Seyedebrahimi R, Sadrjahani M, Kavakebian F Heliyon. 2025; 11(4):e42792.

PMID: 40066039 PMC: 11891681. DOI: 10.1016/j.heliyon.2025.e42792.


Injectable Thermosensitive Thiol-Modified NIPAAm--Chitosan Hydrogels for Cartilage Regeneration in a Rabbit Osteoarthritis Model.

Ching P, Chang Y, Weng C, Wang J, Yeh M ACS Omega. 2025; 10(8):8523-8537.

PMID: 40060830 PMC: 11886913. DOI: 10.1021/acsomega.4c10829.


Water absorption dynamics in medical foam: empirical validation of the Lucas-Washburn model.

Mu W, Sun H, Cao L Eur Phys J E Soft Matter. 2025; 48(3):13.

PMID: 40042719 PMC: 11882628. DOI: 10.1140/epje/s10189-025-00478-3.


Nanofibrous Scaffolds' Ability to Induce Mesenchymal Stem Cell Differentiation for Soft Tissue Regenerative Applications.

Pisani S, Evangelista A, Chesi L, Croce S, Avanzini M, Dorati R Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006052 PMC: 11859969. DOI: 10.3390/ph18020239.


References
1.
Chung H, Park T . Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev. 2007; 59(4-5):249-62. DOI: 10.1016/j.addr.2007.03.015. View

2.
Pham Q, Sharma U, Mikos A . Electrospun poly(epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules. 2006; 7(10):2796-805. DOI: 10.1021/bm060680j. View

3.
Sell S, Barnes C, Simpson D, Bowlin G . Scaffold permeability as a means to determine fiber diameter and pore size of electrospun fibrinogen. J Biomed Mater Res A. 2007; 85(1):115-26. DOI: 10.1002/jbm.a.31556. View

4.
Bollheimer L, Wrede C, Rockmann F, Ottinger I, Scholmerich J, Buettner R . Glucagon production of the rat insulinoma cell line INS-1-A quantitative comparison with primary rat pancreatic islets. Biochem Biophys Res Commun. 2005; 330(1):327-32. DOI: 10.1016/j.bbrc.2005.01.168. View

5.
Pereverzev A, Vajna R, Pfitzer G, Hescheler J, Klockner U, Schneider T . Reduction of insulin secretion in the insulinoma cell line INS-1 by overexpression of a Ca(v)2.3 (alpha1E) calcium channel antisense cassette. Eur J Endocrinol. 2002; 146(6):881-9. DOI: 10.1530/eje.0.1460881. View